ViiV Establishes HIV Drug Manufacturing Partnership in Russia

ViiV Healthcare, an HIV company formed by Pfizer and GlaxoSmithKline, has established a pharmaceutical manufacturing partnership with Russian drugmaker Binnopharm, Reuters reports.

This follows a pledge by a dozen international pharmaceutical companies to invest more than $1 billion in Russia as the country tries to reduce its dependence on drug imports.

Industry research group Pharmexpert says that the Russian market for HIV drugs topped $500 million in 2010, with more than half of those sales coming from two manufacturers—GlaxoSmithKline and Abbott Laboratories.

To read the Reuters article,visit: http://uk.finance.yahoo.com/news/Glaxo-Pfizer-HIV-venture-targetukfocus-3571820764.html?x=0.

The Friends of AIDS Foundation is dedicated to enhancing the quality of life for HIV positive individuals and empowering people to make healthy choices to prevent the spread of the HIV virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.

TOGETHER WE REMAIN STRONG!